Akero Therapeutics Inc (AKRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKRO | AMGN | VRTX | REGN | GSK |
| Company | Akero Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 18.65 | 303.11 | 454.79 | 974.86 | 44.70 |
| High | 19.55 | 303.51 | 454.79 | 978.93 | 44.75 |
| Low | 18.02 | 298.31 | 445.22 | 963.41 | 44.22 |
| Last | 19.50 | 300.19 | 446.88 | 973.16 | 44.24 |
| Change | +1.18 | -5.65 | -10.07 | -11.86 | -0.88 |
| % Change | +6.44% | -1.85% | -2.20% | -1.20% | -1.95% |
| Volume | 1,007,100 | 2,636,700 | 1,379,600 | 336,800 | 2,648,000 |
| 20-Day Average Volume | 649,495 | 2,866,760 | 1,201,070 | 423,390 | 3,851,865 |
| Previous Close | 18.32 | 305.84 | 456.95 | 985.02 | 45.12 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 20.26 | 304.43 | 427.07 | 965.44 | 44.40 |
| 20-Day Raw Stochastic | 36.99% | 55.40% | 83.66% | 78.11% | 62.60% |
| 20-Day Relative Strength | 43.72% | 53.58% | 65.29% | 55.70% | 55.57% |
| Weighted Alpha | +1.91 | +32.49 | +34.88 | +30.46 | +31.40 |
| Today's Opinion | 88% Sell | 72% Buy | 88% Buy | 88% Buy | 88% Buy |
| Previous Opinion | 88% Sell | 88% Buy | 88% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 72% Sell | 72% Sell | 8% Buy | 8% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.18% since 05/20/24 | -4.56% since 05/20/24 | +0.23% since 05/20/24 | -1.43% since 05/20/24 | -0.78% since 05/20/24 |
| Low | 17.88 on 05/24/24 | 298.31 on 05/28/24 | 437.46 on 05/21/24 | 963.41 on 05/28/24 | 44.22 on 05/28/24 |
| High | 20.86 on 05/22/24 | 316.67 on 05/21/24 | 457.66 on 05/24/24 | 997.87 on 05/22/24 | 45.79 on 05/22/24 |
| 1-Month | |||||
| %Chg | -1.22% since 04/26/24 | +11.19% since 04/26/24 | +12.43% since 04/26/24 | +10.19% since 04/26/24 | +7.61% since 04/26/24 |
| Low | 17.88 on 05/24/24 | 268.99 on 04/29/24 | 391.70 on 04/30/24 | 883.20 on 04/29/24 | 41.42 on 04/30/24 |
| High | 22.26 on 05/06/24 | 322.60 on 05/03/24 | 457.66 on 05/24/24 | 997.87 on 05/22/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | -28.39% since 02/28/24 | +8.19% since 02/28/24 | +4.66% since 02/28/24 | -1.46% since 02/28/24 | +4.49% since 02/28/24 |
| Low | 17.88 on 05/24/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 37.00 on 03/04/24 | 322.60 on 05/03/24 | 457.66 on 05/24/24 | 997.87 on 05/22/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | +18.04% since 11/28/23 | +13.06% since 11/28/23 | +28.77% since 11/28/23 | +21.47% since 11/28/23 | +24.13% since 11/28/23 |
| Low | 15.32 on 02/06/24 | 260.68 on 04/19/24 | 346.68 on 11/29/23 | 800.24 on 11/29/23 | 35.35 on 11/29/23 |
| High | 37.00 on 03/04/24 | 329.72 on 02/05/24 | 457.66 on 05/24/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,348,445 | 161,032,416 | 115,318,728 | 107,228,592 | 91,684,752 |
| Shares Outstanding, K | 69,151 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | -151,760,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | -53,340,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | -0.29 | 0.60 | 0.39 | 0.17 | 0.65 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.90 on 05/10/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 05/20/24 | 05/02/24 | 05/06/24 | 05/02/24 | 05/01/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.42 | 30.34 | 26.54 | 11.17 |